Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1061 clinical trials
TDLN-sparing RT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

The goal of this clinical trial is to learn if tumor draining lymph nodes-sparing radiotherapy (TDLN-sparing RT) followed by immunotherapy as maintenance therapy works to treat locally advanced esophageal squamous cell cancer in adults.

  • 0 views
  • 12 May, 2025
  • 1 location
Preliminary Antitumor Activity Safety and Tolerability of Tislelizumab in Combination With Lenvatinib for Hepatocellular Carcinoma

The primary objective of this study is to assess the preliminary antitumor activity as indicated by overall response rate (ORR) of tislelizumab in combination with lenvatinib in participants with unresectable locally advanced or metastatic hepatocellular carcinoma (HCC).

unresectable hepatocellular carcinoma
cholangiocarcinoma
cancer
metastatic hepatocellular carcinoma
liver cancer
  • 0 views
  • 19 Feb, 2024
  • 10 locations
Test trial v7.2 (May 13) - Test 1 (Acro - Test 1)

Test trial v7.2 (May 13) - Test 1

  • 0 views
  • 13 May, 2025
  • 3 locations
Prevention of Preterm Birth by Screening of the Consistency Index and Length of the Uterine Cervix in Women With a Single Pregnancy

Worldwide, about 15 million babies are born too soon every year, causing 1.1 million deaths, as well as shortand long-term disability in countless survivors. Few prognostic tests are available to predict PTB. A short transvaginal ultrasound cervical length (TVU CL) has been shown to be a good predictor of PTB.

perinatal morbidity
premature birth
pregnancy preterm
transvaginal ultrasound
progesterone
  • 0 views
  • 19 Feb, 2024
  • 1 location
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease  

The purpose of this study is to evaluate the safety and efficacy of the ExAblate Model 4000 Type 2.0 System as a tool to disrupt the blood-brain barrier (BBB) in patients with probable Alzheimer's Disease (AD).

alzheimer's disease
  • 0 views
  • 09 May, 2025
  • 3 locations
Molecular Imaging of Prostate Cancer Using Radiofluorinated PSMA Ligand

Additionally, if the patient undergoes a biopsy as standard of care, image features will correlate directly with histopathological findings.Validation of this radiotracer can potentially lead to its use as a standard of care for future imaging and improve diagnosis and treatment guidance.This drug is not approved by the Food and …

MRI
positron emission tomography
fluciclovine (18f)
localized disease
prostate specific antigen
  • 0 views
  • 19 Feb, 2024
  • 1 location
Resilience-Based Diabetes Self-Management Education (RB-DSME) for African Americans

African Americans are twice as likely to have type 2 diabetes as non-Hispanic Whites and are less likely to engage in effective diabetes self-management. There is a critical need for intensive lifestyle interventions that address the distress inherent in having the disease and the unique stressors faced by African Americans …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Promoting Co-Parenting and Reducing Hazardous Drinking in New Families

This study aims to understand if a parenting program that helps couples learn to parent as a team and maintain a healthy lifestyle, such as maintaining safer levels of alcohol use, promotes parent and child health and well-being.

hazardous drinking
heavy drinking
  • 0 views
  • 19 Feb, 2024
  • 2 locations
Accuracy of Non-Invasive Blood Pressure Measurements at the Arm Calf and Finger

The intra-arterial measurement will be the reference measurement. As secondary objectives, the investigators will assess the ability of combined continuous (ClearSight) and intermittent (automatic cuff) non-invasive monitoring to detect stage 2 hypertension, and to detect changes in BP during a cardiovascular intervention (as clinically indicated but not imposed by the …

  • 0 views
  • 19 Feb, 2024
  • 3 locations
Dose Escalation of DF6002 in Patients With Advanced Solid Tumors and Expansion in Selected Indications

This study is a Phase 1/2, open-label, dose-escalation study with a consecutive parallel-group efficacy expansion study, designed to determine the safety, tolerability, PK, pharmacodynamics, and preliminary anti-tumor activity of DF6002 as monotherapy and in combination with pembrolizumab.

non-small cell lung cancer
esophageal carcinoma
platinum-based chemotherapy
immunomodulators
cancer
  • 0 views
  • 19 Feb, 2024
  • 1 location